Literature DB >> 22652793

Structural biology of factor VIIa/tissue factor initiated coagulation.

Kanagasabai Vadivel1, S Paul Bajaj.   

Abstract

Factor VII (FVII) consists of an N-terminal gamma-carboxyglutamic acid domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains and the C-terminal protease domain. Activation of FVII results in a two-chain FVIIa molecule consisting of a light chain (Gla-EGF1-EGF2 domains) and a heavy chain (protease domain) held together by a single disulfide bond. During coagulation, the complex of tissue factor (TF, a transmembrane glycoprotein) and FVIIa activates factor IX (FIX) and factor X (FX). FVIIa is structurally "zymogen-like" and when bound to TF, it is more "active enzyme-like." FIX and FX share structural homology with FVII. Three structural biology aspects of FVIIa/TF are presented in this review. One, regions in soluble TF (sTF) that interact with FVIIa as well as mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in FVIIa and their functions; two, modeled interactive regions of Gla and EGF1 domains of FXa and FIXa with FVIIa/sTF; and three, incompletely formed oxyanion hole in FVIIa/sTF and its induction by substrate/inhibitor. Finally, an overview of the recognition elements in TF pathway inhibitor is provided.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652793      PMCID: PMC3383856          DOI: 10.2741/4066

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  102 in total

1.  Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.

Authors:  K P Hopfner; A Lang; A Karcher; K Sichler; E Kopetzki; H Brandstetter; R Huber; W Bode; R A Engh
Journal:  Structure       Date:  1999-08-15       Impact factor: 5.006

2.  Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.

Authors:  W Ruf; C D Dickinson
Journal:  Trends Cardiovasc Med       Date:  1998-11       Impact factor: 6.677

3.  Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.

Authors:  P F Neuenschwander; J H Morrissey
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

4.  Extensive small-angle X-ray scattering studies of blood coagulation factor VIIa reveal interdomain flexibility.

Authors:  Charlotte Rode Mosbaek; David Nolan; Egon Persson; Dmitri I Svergun; Jens Thostrup Bukrinsky; Bente Vestergaard
Journal:  Biochemistry       Date:  2010-10-20       Impact factor: 3.162

5.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Authors:  B Osterud; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 6.  Structural basis of substrate specificity in the serine proteases.

Authors:  J J Perona; C S Craik
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

7.  The crystal structure of the endothelial protein C receptor and a bound phospholipid.

Authors:  Vaheh Oganesyan; Natalia Oganesyan; Simon Terzyan; Dongfeng Qu; Zbigniew Dauter; Naomi L Esmon; Charles T Esmon
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

8.  Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.

Authors:  Yasuo Shikamoto; Takashi Morita; Zui Fujimoto; Hiroshi Mizuno
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

9.  Purification and properties of human coagulation factor VII.

Authors:  G J Broze; P W Majerus
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

10.  Crystal structure of the extracellular region of human tissue factor.

Authors:  K Harlos; D M Martin; D P O'Brien; E Y Jones; D I Stuart; I Polikarpov; A Miller; E G Tuddenham; C W Boys
Journal:  Nature       Date:  1994-08-25       Impact factor: 49.962

View more
  13 in total

Review 1.  Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

2.  Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.

Authors:  Joshua M Gajsiewicz; Kristin M Nuzzio; Chad M Rienstra; James H Morrissey
Journal:  Biochemistry       Date:  2015-07-27       Impact factor: 3.162

Review 3.  The mechanism underlying activation of factor IX by factor XIa.

Authors:  David Gailani; Yipeng Geng; Ingrid Verhamme; Mao-fu Sun; S Paul Bajaj; Amanda Messer; Jonas Emsley
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

4.  Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Authors:  Janet C Reid; Admire Matsika; Claire M Davies; Yaowu He; Amy Broomfield; Nigel C Bennett; Viktor Magdolen; Bhuvana Srinivasan; Judith A Clements; John D Hooper
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

5.  Influence of membrane composition on the enhancement of factor VIIa/tissue factor activity by magnesium ions.

Authors:  Narjes Tavoosi; James H Morrissey
Journal:  Thromb Haemost       Date:  2013-11-28       Impact factor: 5.249

6.  Metal-dependent amyloid β-degrading catalytic antibody construct.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Mariko Hara; Stephanie A Planque; Yukie Mitsuda; Sudhir Paul
Journal:  J Biotechnol       Date:  2014-04-01       Impact factor: 3.307

7.  Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11.

Authors:  Katheryne Z Edson; Bhagwat Prasad; Jashvant D Unadkat; Yoshitomo Suhara; Toshio Okano; F Peter Guengerich; Allan E Rettie
Journal:  Biochemistry       Date:  2013-11-07       Impact factor: 3.162

8.  Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity.

Authors:  Anna N Ilinskaya; Sonny Man; Anil K Patri; Jeffrey D Clogston; Rachael M Crist; Raul E Cachau; Scott E McNeil; Marina A Dobrovolskaia
Journal:  Nanomedicine (Lond)       Date:  2013-11-27       Impact factor: 5.307

Review 9.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

10.  Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.

Authors:  Aliza Cassel; Nurit Rosenberg; Emad Muhammad; Tami Livnat; Rima Dardik; Miriam Berl; Meir Preis
Journal:  Res Pract Thromb Haemost       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.